Page last updated: 2024-12-07
4-dimethylaminobenzylamine
4-Dimethylaminobenzylamine, also known as N,N-dimethyl-4-aminobenzylamine, is a chemical compound that has garnered attention due to its structural similarity to the neurotransmitter dopamine. Its potential as a precursor for the synthesis of various pharmaceutical agents, including antipsychotics and antidepressants, has driven research interest. This compound is also explored for its potential as a catalyst in organic reactions, particularly in the synthesis of polymers and other organic molecules. While there is no specific information on its effects or importance in the context of human health, its structural similarity to dopamine suggests potential interactions with the dopaminergic system, making it a subject of further investigation.'
Cross-References
ID Source | ID |
PubMed CID | 80826 |
SCHEMBL ID | 295816 |
MeSH ID | M0109502 |
Synonyms (42)
Synonym |
n-[4-(aminomethyl)phenyl]-n,n-dimethylamine |
EN300-13350 |
4-dimethylaminobenzylamine |
19293-58-4 |
4-(n,n-dimethylamino)benzylamine |
para-dimethylaminobenzylamine |
EU-0033353 |
STK503378 |
4-(aminomethyl)-n,n-dimethylaniline |
C90108 |
AKOS000264243 |
HMS1648B11 |
p-dimethylaminobenzylamine |
benzenemethanamine, 4-(dimethylamino)- |
einecs 229-033-0 |
nsc 207808 |
1,4-dichlorocyclohexane; 4-(dimethylamino)-benzylamine |
A813619 |
4-(dimethylamino)benzylamine |
[4-(aminomethyl)phenyl]dimethylamine |
benzenemethanamine,4-(dimethylamino)- |
FT-0637822 |
FS-1747 |
4-(aminomethyl)-n,n-dimethylbenzenamine |
SCHEMBL295816 |
PDJZOFLRRJQYBF-UHFFFAOYSA-N |
(4-dimethylaminophenyl)methylamine |
mfcd00466364 |
gabapentinenacarbil |
W-206422 |
4-(dimethylamino)-benzylamine |
DTXSID30940965 |
AMY15242 |
BBL037746 |
CS-0096267 |
SB76599 |
SY069455 |
Z90122421 |
[[4-(dimethylamino)phenyl]methyl]amine |
S273H97VEA |
p-(n,n-dimethylamino)benzylamine |
4-(dimethylamino)benzenemethanamine |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.47
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.47 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |